18.23
1.67%
-0.31
Dopo l'orario di chiusura:
18.23
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché SDGR Giù?
Forum
Previsione
Precedente Chiudi:
$18.54
Aprire:
$18.46
Volume 24 ore:
993.57K
Relative Volume:
1.52
Capitalizzazione di mercato:
$1.32B
Reddito:
$188.48M
Utile/perdita netta:
$-143.14M
Rapporto P/E:
32.55
EPS:
0.56
Flusso di cassa netto:
$-158.83M
1 W Prestazione:
-6.70%
1M Prestazione:
+2.42%
6M Prestazione:
-19.90%
1 anno Prestazione:
-40.93%
Schrodinger Inc Stock (SDGR) Company Profile
Nome
Schrodinger Inc
Settore
Industria
Telefono
503-299-1150
Indirizzo
1540 BROADWAY, NEW YORK, NY
Confronta SDGR con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
SDGR | 18.23 | 1.32B | 188.48M | -143.14M | -158.83M | 0.56 |
VEEV | 213.68 | 34.73B | 2.57B | 615.26M | 996.76M | 3.32 |
SOLV | 67.12 | 11.43B | 8.25B | 404.00M | 1.52B | 0.00 |
DOCS | 52.21 | 9.58B | 493.63M | 160.55M | 162.20M | 0.55 |
HQY | 102.40 | 8.82B | 1.10B | 105.67M | -197.98M | 0.1475 |
TEM | 54.06 | 8.51B | 640.44M | -743.28M | -206.93M | 0.00 |
Schrodinger Inc Stock (SDGR) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2023-12-05 | Iniziato | KeyBanc Capital Markets | Overweight |
2023-05-05 | Ripresa | Piper Sandler | Overweight |
2022-12-19 | Iniziato | Goldman | Neutral |
2022-03-01 | Iniziato | Citigroup | Buy |
2021-11-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
2021-11-19 | Iniziato | Piper Sandler | Overweight |
2021-11-11 | Downgrade | BofA Securities | Buy → Neutral |
2021-10-13 | Iniziato | Berenberg | Buy |
2021-09-01 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
2021-05-25 | Iniziato | Craig Hallum | Buy |
2020-11-23 | Aggiornamento | BofA Securities | Neutral → Buy |
2020-10-12 | Aggiornamento | Jefferies | Hold → Buy |
2020-03-02 | Iniziato | BMO Capital Markets | Outperform |
2020-03-02 | Iniziato | Jefferies | Hold |
2020-03-02 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Schrodinger Inc Borsa (SDGR) Ultime notizie
Schrödinger Broadens and Accelerates Predictive Toxicology Initiative - BioSpace
Schrödinger Secures $9.5M Gates Foundation Grant to Expand Drug Discovery Platform | SDGR Stock News - StockTitan
Sumitomo Mitsui Trust Group Inc. Increases Stake in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Leerink Partnrs Decreases Earnings Estimates for Schrödinger - MarketBeat
(SDGR) Technical Data - Stock Traders Daily
Schrodinger Inc (SDGR) Quarterly 10-Q Report - Quartzy
Schrodinger (SDGR): Stock Experiences 5% Decline Amid Market Flu - GuruFocus.com
Pier 88 Investment Partners LLC Buys 35,120 Shares of Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Schrödinger Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Midtown-based drug company inks $150M deal with Novartis - Crain's New York Business
Rubric Capital Management LP Increases Stake in Schrodinger Inc - GuruFocus.com
Schrödinger, Inc. Provides Earnings Guidance for the Fiscal Year Ending December 31, 2024 - Marketscreener.com
Schrodinger shares target increased, outperform rating on Novartis deal - Investing.com
Flare and Schrödinger join multibillion-dollar collaborations - BioWorld Online
Schrödinger announces collaboration with Novartis - The Pharma Letter
Schrödinger, Inc. (NASDAQ:SDGR) Q3 2024 Earnings Call Transcript - Insider Monkey
Schrodinger announces expanded license agreement with Novartis - Yahoo Finance
Baillie Gifford & Co. Has $36.75 Million Stock Position in Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Market Participants Recognise Schrödinger, Inc.'s (NASDAQ:SDGR) Revenues Pushing Shares 26% Higher - Simply Wall St
Earnings call: Schrödinger reports dip in Q3 revenue, eyes Novartis deal - Investing.com UK
Schrodinger Inc (SDGR) Q3 2024 Earnings Call Highlights: Navigat - GuruFocus.com
Schrodinger Inc (SDGR) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges and ... By GuruFocus - Investing.com Canada
Schrodinger Inc (SDGR) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges and ... - Yahoo Finance
Schrödinger Reports Q3 2024 Earnings and New Novartis Collaboration - TipRanks
Schrödinger secures Novartis deal with potential $2.3 billion payout By Investing.com - Investing.com Australia
Schrödinger gains on Novartis deal despite Q3 miss - MSN
Blade Air Mobility Delivers Q3 Earnings Beat And Strong Margins As Restructuring Takes Flight - AOL
Schrodinger Inc (SDGR) Stock Price Up 13.36% on Nov 12 - GuruFocus.com
Schrödinger’s stock pops as it enters collaboration pact with Novartis worth up to $2.5 billion - MSN
Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details - Yahoo Finance
Schrödinger surges on Novartis collaboration agreement - ShareCast
Market news - Research the market
Schrödinger, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Schrodinger, Inc. (SDGR) Reports Q3 Loss, Misses Revenue Estimates - Yahoo Finance
Schrödinger secures Novartis deal with potential $2.3 billion payout - Investing.com
Schrödinger enters collaboration pact with Novartis worth up to $2.5 billion - MarketWatch
Schrödinger Reports Third Quarter 2024 Financial Results - Business Wire
Schrödinger, Inc. Announces Multi-Target Collaboration and Expanded Software Licensing Agreement with Novartis - Marketscreener.com
Schrodinger Inc (SDGR) Q3 2024 Earnings Report Preview: What to Expect - GuruFocus.com
Schrödinger, Inc. (NASDAQ:SDGR) Shares Sold by ARK Investment Management LLC - MarketBeat
Schrödinger (SDGR) to Release Quarterly Earnings on Tuesday - MarketBeat
Schrödinger to Present at Jefferies London Healthcare Conference - BioSpace
(SDGR) Long Term Investment Analysis - Stock Traders Daily
How to Profit From an AI-Driven Biotech That Has Lost Half Its Value in 2024 - RealMoney
Schrödinger, Inc. (NASDAQ:SDGR) Shares Acquired by Stephens Investment Management Group LLC - MarketBeat
Schrödinger to Announce Third Quarter 2024 Financial Results on November 12 - Business Wire
Schrödinger, Inc. (NASDAQ:SDGR) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Trading (SDGR) With Integrated Risk Controls - Stock Traders Daily
Stanley Laman Group Ltd. Sells 33,556 Shares of Schrödinger, Inc. (NASDAQ:SDGR) - MarketBeat
Schrödinger Presents SGR-3515 Preclinical Data at 2024 EORTC-NCI-AACR Symposium - Business Wire
Schrödinger (NASDAQ:SDGR) Stock Price Up 6.2%Time to Buy? - MarketBeat
Schrodinger Inc Azioni (SDGR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):